Vanguard Personalized Indexing Management’s DexCom DXCM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.86M | Buy |
44,260
+5,763
| +15% | +$503K | 0.04% | 359 |
|
|
2025
Q1 | $2.63M | Sell |
38,497
-1,254
| -3% | -$85.6K | 0.04% | 407 |
|
|
2024
Q4 | $3.09M | Buy |
39,751
+5,700
| +17% | +$443K | 0.05% | 340 |
|
|
2024
Q3 | $2.28M | Sell |
34,051
-5,355
| -14% | -$359K | 0.04% | 431 |
|
|
2024
Q2 | $4.46M | Sell |
39,406
-1,110
| -3% | -$126K | 0.08% | 198 |
|
|
2024
Q1 | $5.62M | Buy |
40,516
+2,544
| +7% | +$353K | 0.12% | 151 |
|
|
2023
Q4 | $4.71M | Buy |
37,972
+983
| +3% | +$122K | 0.12% | 144 |
|
|
2023
Q3 | $3.45M | Sell |
36,989
-2,181
| -6% | -$203K | 0.1% | 183 |
|
|
2023
Q2 | $5.03M | Buy |
39,170
+2,164
| +6% | +$278K | 0.15% | 110 |
|
|
2023
Q1 | $4.3M | Buy |
37,006
+5,493
| +17% | +$638K | 0.15% | 118 |
|
|
2022
Q4 | $3.57M | Buy |
31,513
+9,692
| +44% | +$1.1M | 0.15% | 131 |
|
|
2022
Q3 | $1.76M | Buy |
21,821
+8,214
| +60% | +$661K | 0.08% | 258 |
|
|
2022
Q2 | $1.01M | Buy |
13,607
+1,331
| +11% | +$99.2K | 0.05% | 455 |
|
|
2022
Q1 | $1.57M | Buy |
12,276
+3,200
| +35% | +$409K | 0.08% | 258 |
|
|
2021
Q4 | $1.22M | Buy |
9,076
+3,024
| +50% | +$406K | 0.07% | 306 |
|
|
2021
Q3 | $827K | Buy |
6,052
+2,304
| +61% | +$315K | 0.07% | 285 |
|
|
2021
Q2 | $400K | Sell |
3,748
-2,848
| -43% | -$304K | 0.04% | 597 |
|
|
2021
Q1 | $593K | Buy |
6,596
+2,672
| +68% | +$240K | 0.09% | 268 |
|
|
2020
Q4 | $363K | Buy |
3,924
+340
| +9% | +$31.5K | 0.08% | 297 |
|
|
2020
Q3 | $369K | Buy |
3,584
+544
| +18% | +$56K | 0.1% | 235 |
|
|
2020
Q2 | $308K | Buy |
+3,040
| New | +$308K | 0.14% | 182 |
|